Find Partners (Suppliers) who Provide:
Drug Substance (CDMO/CRO)
Filters
Production region
Production scale
Qualifications
Follow us
CDMO-CRO
Plants in:
Established in: 1998
Production scale:
small
medium
large
Employees: 1000
Facilities with global regulatory compliance
Customized and Flexible Collaboration Models
End-to-end drug discovery
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2023
Production scale:
small
medium
large
Employees: 1000+
Expertise in Conventional, Complex, and Niche Chemistries
End-to-end Support from early development to Commercial Phases
Comprehensive Analytical Support Facilities
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1886
Production scale:
medium
small
Employees: 275+
Raw materials, CMO and OTC products
Two GMP certified locations
Customisable (small-sized) packages
All certificates
Replies quickly
CDMO-CRO
Specialized in complex product development and manufacturing.
High-quality standards with a focus on customer-specific needs.
Agile and innovative approach to CDMO services.
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2008
Production scale:
large
small
medium
Employees: 4.000
With 14 production sites in Europe and the USA
7 Development Centers of Excellence covering all dosage forms
13 locations with Technology Services on site for seamless Tech Transfer and product Life-Cycle Management
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2013
Production scale:
medium
Employees: 25+
ISO9001 certified
Drug R&D center (in Hangzhou)
From lab scale (mg/g) to commercial scale (kgs/tons)
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1991
Production scale:
small
medium
large
Employees: 3,500+
More than 12 GMP manufacturing facilities (EU, US, India)
Portfolio of more than 240 commercial APIs
We are experts in the cGMP production of highly potent compounds
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1951
Production scale:
medium
Employees: 455+
Largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market.
FDA approved european manufcaturing facilities
Export APIs to more than 60 countries worldwide
All certificates
Replies quickly
Plants in:
Established in: 2014
Production scale:
small
medium
large
Employees: 1000+
23 years of production experience
6 workshops and 9 production lines which has 100t/month production capacity
4 USDMFS & 5 CEPS & 200+ Patents
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1972
Production scale:
medium
Employees: 1,000+
EU-GMP for APIs and CEP for certain APIs
Exporting to over 50 countries worldwide
Long-standing technological advantage in adamantane, quinuclidine and nitrofurane chemistry
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1964
Production scale:
small
medium
large
Employees: 135+
Market leader in Switzerland
Small and medium batch sizes
Pharmaceutical raw materials with a herbal or synthetic basis
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2021
Production scale:
small
Employees: 19
API, Intermediates, Building Blocks, Impurities, Amino acids and Peptides
Small quantity APIs to commercial scale
GMP and USFDA certification based on quantity, order, assignment.
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2019
Production scale:
large
Employees: 10+
Focused on pharmaceutical industry
Reasonable price for the customers
Full service from R&D stage to commercial stage
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1993
Production scale:
small
medium
large
Employees: 600
Integrated innovative platforms for Technology Transfer (TT&GO®)
Fermentation, purification, and chemical synthesis technologies on the same site
Scalability from Laboratory and Pilot to Industrial scales
All certificates
Replies quickly
Plants in:
Established in: 2008
Production scale:
large
medium
Employees: 300+
More than 150 patents based on independent intelligence
Expertise in anti-tumor, anti-diabetes and cardiovascular API and intermediates.
GMP facility with annual production capacity of 300M
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2006
Production scale:
small
medium
large
Employees: 3500
Silver EcoVadis awardee committed to sustainability
Exceptional synthesis experience of HPAPIs
One-stop CDMO Solutions for APl and Key intermediates
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1989
Production scale:
large
Employees: 5000+
6 production facilities approved by USFDA, AGES-Austria, PMDA, WHO
R&D Centers with capabilities of ANDAs, DMFs and NDDS
462+ patents filed for drug substances and polymorphs
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2003
Production scale:
large
Employees: 4000+
20+ years’ expertise in API manufacturing, trusted for quality and global compliance.
Listed pharma leader in China, prioritizing transparency and regulatory excellence.
End-to-end integration from R&D to scalable production, delivering cost-efficient solutions.
All certificates
Replies quickly
Plants in:
Established in: 1982
Production scale:
small
Employees: 30+
Modern GMP facility
Team of academics and technical experts
Small to large batch sizes possible
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1980
Production scale:
medium
Employees: 30+
EU-GMP and DIN EN ISO 9001:2015
Pioneer in the fractionation of sheep plasma
Pure & sterile high-quality products
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2006
Production scale:
small
medium
Employees: 20
Quality Assurance: Products are manufactured from the finest raw materials and undergo rigorous testing.
Tailored Customisation & Compliance: Providing end-to-end solutions to meet your business
Dependable Expertise and Supply: Backed by years of industry experience and a robust supply chain.
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2012
Production scale:
medium
Employees: 180
A high-tech enterprise with 13 own patents granted
Strong R&D system with ISO9001 / ISO14001 / OHSAS18001 certification
Provide professional CMO & CDMO service
All certificates
Replies quickly
Certified by US FDA
Well-Established Environmental, Health & Safety Protocols
Seasoned Project Execution Team
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1965
Production scale:
small
medium
large
Employees: 600+
Pharmaceutical-quality dextrans meeting the highest standards and complying with major pharmacopeias
Manufactured in a cGMP facility in Denmark, inspected by both the FDA and EMA
Documented quality and certifications from the US FDA and EDQM for smooth regulatory submission
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1987
Production scale:
medium
small
large
Employees: 50+
ISO 9001:2015 & SGS audited supplier
One-stop CDMO Solutions for APl and Key intermediates
Specialized in APIs & Pharmaceutical Intermediates for 38 years
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1952
Production scale:
small
medium
large
Employees: 550+
API manufacturing (Innovators, Generics and Highly Potent)
A tailor-made and flexible service approach
State-of-the-art analytical services including solid form and QbD laboratories
All certificates
Replies quickly
CDMO-CRO
Pioneering in advanced delivery technologies and development solutions.
Extensive global network ensuring supply chain resilience.
Tailored services across biologics, gene therapies, and pharmaceuticals.
All certificates
Replies slower than most
CDMO-CRO
Plants in:
Established in: 1996
Production scale:
large
small
medium
Leading in biopharmaceutical development and biologic API production.
Comprehensive services from cell line development to commercial manufacturing.
Strong track record in delivering complex and high-quality biologics.
All certificates
Replies quickly
CDMO-CRO
Specialized in liquid and semi-solid pharmaceuticals manufacturing.
Nordic excellence in quality and reliability.
Flexible production capabilities catering to a wide range of batch sizes.
All certificates
Replies slower than most
CDMO-CRO
Strong heritage in pharmaceutical innovation and biotechnology.
Comprehensive range of services from early development to commercial supply.
Focus on quality, reliability, and sustainability in biopharmaceutical manufacturing.
All certificates
Replies slower than most
CDMO-CRO
Expertise in cell therapy development and manufacturing.
Tailored solutions for autologous and allogeneic cell therapies.
Cutting-edge technology for scalable and efficient cell therapy production.
All certificates
Replies slower than most
CDMO-CRO
Comprehensive drug development services from molecule to market.
Expertise in nanomedicine and drug repurposing.
Tailored project management ensuring efficiency and transparency.
All certificates
Replies slower than most
CDMO-CRO
Plants in:
Established in: 2002
Production scale:
large
Specialized in biologics CDMO services with a focus on monoclonal antibodies.
Advanced facilities for clinical and commercial-scale manufacturing.
Strong commitment to quality and regulatory compliance.
All certificates
Replies slower than most
Looking for Drug Substance Services?
Find a list of providers specializing in Drug Substance (CDMO/CRO). Navigate through our extensive selection to identify the supplier that aligns with your specific needs.
Pharmaoffer makes it easy and convenient to send inquiries at no cost. Directly connect with your chosen supplier and take the first step towards fulfilling your pharmaceutical needs easily and efficiently.
Drug Substance (CDMO/CRO)
Drug Substance CDMOs and CROs provide essential services in the development and manufacturing of active pharmaceutical ingredients (APIs). These organizations specialize in early-stage research, process development, and GMP-compliant manufacturing of drug substances for clinical and commercial use.
Pharmaoffer's Drug Substance CDMO/CRO category includes partners with expertise in small molecules, biologics, peptides, and complex chemistry, all operating under strict regulatory compliance. These providers help companies scale from lab to market efficiently and cost-effectively.
Key Functions of Drug Substance CDMOs/CROs:
API Research and Development: Providing early-stage discovery support, custom synthesis, and process optimization to streamline the development of drug substances.
Process Scale-Up and Tech Transfer: Transitioning from bench-scale to pilot and commercial scale production with validated methods and reproducibility.
GMP Manufacturing: Delivering high-quality API batches in GMP-certified environments, adhering to FDA, EMA, and other international standards.
Analytical Services: Offering comprehensive analytical method development and validation to ensure consistent quality and regulatory compliance.
Flexible and Specialized Capabilities: From small molecule synthesis to biologic and peptide manufacturing, these partners provide specialized services tailored to product-specific needs.
Explore Leading API CDMOs and CROs
Pharmaoffer connects you with trusted CDMOs and CROs for drug substance development. Our platform enables seamless access to specialized service providers equipped to support your API lifecycle from discovery to commercialization.
